AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. (ATXI) Stock Price, Quote, News & History

ATXIOTCPK
$0.4200
-0.43-50.71%
At close: Mar 17, 5:00 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-1.09M
Investing Cash Flow (TTM)
-
Financing Cash Flow (TTM)
0
Free Cash Flow (TTM)
-1.09M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-1.09M

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
-$1.49M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
0.64
PB Ratio (TTM)
0.77
Earnings Yield % (TTM)
-185.71%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.36

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$2.42M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$0.42
Volume / Avg.
0 / 6.12K
Day Range
- - -
52 Wk Range
0.15 - 0.97
Market Cap
-
P/E Ratio
-
Dividend Yield
-
Exchange
OTC
RSI
-
Short Interest
-
Days to Cover
1

About

Sector
Health Care
Industry
Pharmaceuticals
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It is focused on advancing impactful therapies with the potential to overco...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. (ATXI) stock?

A

You can purchase shares of AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. (OTCPK:ATXI) through any online brokerage.

View our list of the best stock brokerages

Q

Who are AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. (ATXI) competitors?

A

There are no as such competitors for AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc..

Q

What is the forecast, or price target, for AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. (ATXI) stock?

A

AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. has a consensus price target of $0.75.

Q

What is the current price for AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. (ATXI)?

A

The stock price for AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. (OTCPK: ATXI) is $0.28 last updated June 1, 2026 at 3:22 PM EDT.

Q

Does AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. (ATXI) pay a dividend?

A

There are no upcoming dividends for AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc..

Q

When is AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. (OTCPK:ATXI) reporting earnings?

A

AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. does not have any upcoming earnings scheduled.

Q

Is AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. (ATXI) going to split?

A

There is no upcoming split for AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc..

Q

What sector and industry does AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. (ATXI) operate in?

A

AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCPK.